JP Morgan Chase
OM icon

JP Morgan Chase’s Outset Medical OM Stock Holding History

JP Morgan Chase’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.46K Sell
1,493
-99,484
-99% -$435K ﹤0.01% 7012
2026
Q1 		$365K Sell
100,977
-8,399
-8% -$34.4K ﹤0.01% 5197
2025
Q4 		$406K Sell
109,376
-6,930
-6% -$59.4K ﹤0.01% 5161
2025
Q3 		$1.64M Buy
116,306
+107,854
+1,276% +$1.68M ﹤0.01% 4228
2025
Q2 		$162K Buy
8,452
+7,344
+663% +$115K ﹤0.01% 5350
2025
Q1 		$12.3K Buy
1,108
+731
+194% +$8.71K ﹤0.01% 6256
2024
Q4 		$6.29K Sell
377
-683
-64% -$8.52K ﹤0.01% 6474
2024
Q3 		$10.8K Sell
1,060
-203,851
-99% -$6.06M ﹤0.01% 6356
2024
Q2 		$11.8M Sell
204,911
-2,736
-1% -$134K ﹤0.01% 2303
2024
Q1 		$6.91M Sell
207,647
-123,100
-37% -$6.23M ﹤0.01% 2806
2023
Q4 		$26.8M Sell
330,747
-9,614
-3% -$782K ﹤0.01% 1612
2023
Q3 		$55.5M Buy
340,361
+16,378
+5% +$3.87M 0.01% 1070
2023
Q2 		$106M Sell
323,983
-5,285
-2% -$1.61M 0.01% 796
2023
Q1 		$90.9M Buy
329,268
+28,171
+9% +$10.3M 0.01% 828
2022
Q4 		$117M Sell
301,097
-35,233
-10% -$9.94M 0.02% 715
2022
Q3 		$80.4M Sell
336,330
-9,765
-3% -$2.61M 0.01% 811
2022
Q2 		$77.1M Buy
346,095
+142,680
+70% +$61.4M 0.01% 857
2022
Q1 		$139M Buy
203,415
+6,959
+4% +$4.19M 0.02% 701
2021
Q4 		$136M Buy
196,456
+7,082
+4% +$5.24M 0.02% 739
2021
Q3 		$140M Buy
189,374
+45,866
+32% +$31.3M 0.02% 710
2021
Q2 		$108M Buy
143,508
+87,125
+155% +$66.6M 0.01% 866
2021
Q1 		$46M Buy
56,383
+501
+0.9% +$387K 0.01% 1198
2020
Q4 		$47.6M Buy
55,882
+33,740
+152% +$26M 0.01% 1097
2020
Q3 		$16.5M Buy
+22,142
New +$18.2M ﹤0.01% 1625

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

JP Morgan Chase's OM Position: Q2 2026 in Review

JP Morgan Chase reduced its Outset Medical (OM) stake by 99% in Q2 2026, selling an estimated $435K and leaving 1,493 shares worth $6.46K. The position accounts for ﹤0.01% of the portfolio, ranked #7012.

JP Morgan Chase first reported a position in OM in Q3 2020 and has held it in 24 quarters since. The position peaked at $140M in Q3 2021. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • JP Morgan Chase held 1,493 shares of Outset Medical worth $6.46K as of Q2 2026.
  • JP Morgan Chase sold 99,484 Outset Medical shares in Q2 2026, an estimated $435K.
  • Outset Medical made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7012 holding.
  • JP Morgan Chase first reported a position in Outset Medical in Q3 2020 and has held it in 24 quarters since.
  • JP Morgan Chase's Outset Medical position peaked at $140M in Q3 2021.
  • 93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.